Optical Coherence Tomographic Evaluation of Hyperacute Bivalirudin-Induced Coronary Stent Thrombosis
Publication Date
8-1-2017
Journal
The Texas Heart Journal
DOI
10.14503/THIJ-16-6075
PMID
28878581
Publication Date(s)
August 2017
Language
English
PMCID
PMC5577953
PubMedCentral® Posted Date
8-1-2017
PubMedCentral® Full Text Version
Post-Print
Published Open-Access
yes
Keywords
Angioplasty, balloon, coronary/adverse effects; anticoagulants/adverse effects/therapeutic use; coronary thrombosis/diagnostic imaging/prevention & control; percutaneous coronary intervention/adverse effects; stents; time factors; tomography, optical coherence/therapeutic use; treatment outcome
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Abstract
Thrombus formation after stent deployment has been linked to the use of heparin and of antithrombotic agents, such as bivalirudin, during percutaneous coronary intervention. Fluoroscopy has been used to identify stent thrombosis, typically after patients become symptomatic. We describe our use of optical coherence tomography to diagnose and evaluate intraprocedural stent thrombosis in a 68-year-old man who was given bivalirudin just before a percutaneous coronary procedure. This imaging method enabled immediate therapeutic intervention.